We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Alexandria Real Estate Equities Inc (ARE) USD0.01

Sell:$99.29 Buy:$99.38 Change: $0.53 (0.54%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$99.29
Buy:$99.38
Change: $0.53 (0.54%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:$99.29
Buy:$99.38
Change: $0.53 (0.54%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Alexandria Real Estate Equities, Inc. is a life science real estate investment trust. The Company is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. It has a Labspace asset base predominantly concentrated in markets with barriers to entry.

Contact details

Address:
26 North Euclid Avenue
PASADENA
91101
United States
Telephone:
+1 (626) 5780777
Website:
https://www.are.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ARE
ISIN:
US0152711091
Market cap:
$17.29 billion
Shares in issue:
174.76 million
Sector:
Health Care REITs
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Joel Marcus
    Founder, Executive Chairman of the Board
  • Peter Moglia
    Chief Executive Officer, Chief Investment Officer
  • Marc Binda
    Chief Financial Officer, Treasurer
  • Hunter Kass
    Co-President and Regional Market Director, Greater Boston
  • Daniel Ryan
    Co-President and Regional Market Director, San Diego
  • Joseph Hakman
    Co-Chief Operating Officer, Chief Strategic Transactions Officer
  • John Cole
    Executive Vice President - Capital Markets/Strategic Operations and Co-Regional Market Director, Seattle
  • John Cunningham
    Executive Vice President - Regional Market Director, New York City
  • Gary Dean
    Executive Vice President - Real Estate Legal Affairs
  • Kristina Fukuzaki-Carlson
    Executive Vice President - Business Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.